Table 2. Predictors of CF-LVAD Utilization on Waitlist.

	Univariable Analysis		Multivariable Analysis
Risk Factors	Odds Ratio (95% CI)	p-value	Odds Ratio (95% CI)	p-value
Patient characteristics
Male Gender	1.52 (1.42 – 1.61)	<0.001	1.40 (1.30 – 1.51)	<0.001
Ethnicity		<0.001		<0.001
White	(Reference)		(Reference)
African American	1.30 (1.22 – 1.39)		1.15 (1.06 – 1.24)
Hispanic	0.85 (0.77 – 0.95)		0.90 (0.79 – 1.03)
Other	0.63 (0.60 – 0.65)		0.85 (0.72 – 1.00)
Diabetes	1.25 (1.18 – 1.33)	<0.001	1.07 (0.99 – 1.14)	0.071
Smoking	1.35 (1.28 – 1.43)	<0.001	1.19 (1.12 – 1.27)	<0.001
Function Status		<0.001		<0.001
Excellent	(Reference)		(Reference)
Moderate	0.95 (0.89 – 1.01)		1.31 (1.21 – 1.43)
Poor	1.17 (1.08 – 1.28)		1.68 (1.51 – 1.88)
AICD	1.07 (1.01 – 1.14)	0.033	0.96 (0.89 – 1.05)	0.390
Blood Type O	1.40 (1.33 – 1.48)	<0.001	1.62 (1.52 – 1.73)	<0.001
BSA > 2.25	1.68 (1.57 – 1.79)	<0.001	1.52 (1.39 – 1.65)	<0.001
Diagnosis		<0.001		<0.001
Dilated Myopathy	(Reference)		(Reference)
Non-Dilated Myopathy	0.18 (0.16 – 0.20)	<0.001	0.19 (0.17 – 0.22)
UNOS Status @ Listing		<0.001		<0.001
Status 1A	(Reference)		(Reference)
Status 1B	1.06 (0.99 – 1.13)		0.71 (0.66 – 0.78)
Status 2	0.85 (0.80 – 0.90)		0.21 (0.19 – 0.23)
UNOS Region		<0.001		<0.001
1	1.06 (0.92 – 1.22)		1.00 (0.63 – 1.58)
2	(Reference)		(Reference)
3	0.69 (0.62 – 0.77)		0.38 (0.24 – 0.60)
4	0.80 (0.71 – 0.89)		0.78 (0.51 – 1.18)
5	0.69 (0.62 – 0.76)		2.41 (1.50 – 3.86)
6	2.20 (1.86 – 2.62)		3.57 (2.17 – 5.89)
7	1.51 (1.35 – 1.69)		3.79 (2.42 – 5.94)
8	0.96 (0.84 – 1.09)		1.73 (1.11 – 2.68)
9	1.30 (1.15 – 1.47)		1.22 (0.86 – 1.72)
10	1.49 (1.33 – 1.68)		3.18 (1.84 – 5.50)
11	1.41 (1.27 – 1.57)		3.75 (2.42 – 5.80)